Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.165
+0.075 (2.43%)
May 20, 2026, 11:19 AM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $35.48 million as of May 20, 2026. Its market cap has decreased by -10.37% in one year.
Market Cap
35.48M
Enterprise Value
28.37M
1-Year Change
-10.37%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $35.48M, an increase of 16.97%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 34.64M | 2.20% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 36.48M |
| RenovoRx | 35.29M |
| Evaxion | 34.11M |
| Veru Inc. | 34.03M |
| NextCure | 33.37M |
| Grace Therapeutics | 33.35M |
| Aligos Therapeutics | 33.17M |
| NanoViricides | 32.61M |